Evidence map›Paper›PMID 35223856›Full record

ArticleFrontiers in cell and developmental biology2022

Anosmin-1-Like Effect of UMODL1/Olfactorin on the Chemomigration of Mouse GnRH Neurons and Zebrafish Olfactory Axons Development.

Elia Di Schiavi, Giulio Vistoli, Roberta Manuela Moretti, Ilaria Corrado, Giulia Zuccarini, Silvia Gervasoni, Lavinia Casati, Daniele Bottai, Giorgio Roberto Merlo, Roberto Maggi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elia Di SchiaviInstitute of Biosciences and Bioresources, National Research Council of Italy, Naples, Italy.
Giulio VistoliDepartment of Pharmaceutical Sciences DISFARM, Università degli Studi di Milano, Milano, Italy.
Roberta Manuela MorettiDepartment of Pharmacological and Biomolecular Sciences DISFEB, Università degli Studi di Milano, Milano, Italy.
Ilaria CorradoDepartment Molecular Biotechnology and Health Science, University of Torino, Torino, Italy.
Giulia ZuccariniDepartment Molecular Biotechnology and Health Science, University of Torino, Torino, Italy.
Silvia GervasoniDepartment of Pharmaceutical Sciences DISFARM, Università degli Studi di Milano, Milano, Italy.
Lavinia CasatiDepartment of Pharmaceutical Sciences DISFARM, Università degli Studi di Milano, Milano, Italy.
Daniele BottaiDepartment of Pharmaceutical Sciences DISFARM, Università degli Studi di Milano, Milano, Italy.
Giorgio Roberto MerloDepartment Molecular Biotechnology and Health Science, University of Torino, Torino, Italy.
Roberto MaggiDepartment of Pharmaceutical Sciences DISFARM, Università degli Studi di Milano, Milano, Italy.
University of Milan · ITUniversity of Turin · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impairment of development/migration of hypothalamic gonadotropin-releasing hormone (GnRH) neurons is the main cause of Kallmann's syndrome (KS), an inherited disorder characterized by hypogonadism, anosmia, and other developmental defects. Olfactorin is an extracellular matrix protein encoded by the

Indexed as

anosmiaanosmin-1developmentGnRH (gonadotropin-releasing hormone)hypothalamus and neuroendocrinologyolfactorinolfactory axonsUMODL1

Identifiers

PMID35223856
PMCPMC8874799
OpenAlexW4211049961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.